Patents by Inventor Randall E. Lis

Randall E. Lis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 5-pyrimdineamine derivatives
    Patent number: 5318975
    Abstract: This invention relates to novel 5-pyrimidineamine derivatives. The compounds of the invention exhibit cardiovascular properties, particularly mixed vasodilative, selective venous and arterial dilation. Pharmaceutical compositions are proposed for the compounds.
    Type: Grant
    Filed: February 16, 1993
    Date of Patent: June 7, 1994
    Assignee: Berlex Laboratories, Inc.
    Inventor: Randall E. Lis
  • Derivatized alkanolamines as cardiovascular agents
    Patent number: 5051423
    Abstract: Novel derivatized alkanolamines of the following structural formula ##STR1## are described as useful cardiovascular agents. Most especially described is their usefulness as cardiovascular agents exhibiting an antiarrhythmic effect. Said antiarrhythmic effect is of a combination Class II/Class III variety. Pharmaceutical formulations containing such compounds are also described.
    Type: Grant
    Filed: July 13, 1988
    Date of Patent: September 24, 1991
    Assignee: Schering AG
    Inventors: Randall E. Lis, William C. Lumma, Jr., Thomas K. Morgan, Jr., Klaus Nickisch, Ronald A. Wohl
  • 1-(4-Substituted phenyl)-1H-imidazoles compounds
    Patent number: 4851526
    Abstract: Novel 1-(4-substituted phenyl)-1H-imidazoles and their use as antiarrhythmic, anti-hypertensive and anti-ischemic agents is described. Pharmaceutical formulations containing such compounds are also discussed.
    Type: Grant
    Filed: September 4, 1987
    Date of Patent: July 25, 1989
    Assignee: Schering A.G.
    Inventors: Stanley S. Greenberg, Randall E. Lis, William C. Lumma, Jr., Klaus Nickisch, Ronald A. Wohl
  • Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic agents
    Patent number: 4804662
    Abstract: Novel substituted 4-[1H-imidazol-1-yl]benzamides and their use in the treatment of cardiac arrthythmias especially as Class III or combination Class I/III antiarrhythmic agents is described. Pharmaceutical formulations containing such compounds are also disclosed.
    Type: Grant
    Filed: May 5, 1987
    Date of Patent: February 14, 1989
    Assignee: Schering A.G.
    Inventors: Klaus Nickisch, Randall E. Lis, William C. Lumma, Jr., Thomas K. Morgan, Jr., Ronald A. Wohl